|
NECAP1 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64024349658121E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.41593461586854E-12 |
| Normal-vs-Stage2 |
3.67649999999387E-06 |
| Normal-vs-Stage3 |
1.346145417358E-12 |
| Normal-vs-Stage4 |
3.34659966405582E-10 |
| Stage1-vs-Stage2 |
6.766200E-01 |
| Stage1-vs-Stage3 |
2.693900E-02 |
| Stage1-vs-Stage4 |
8.722000E-02 |
| Stage2-vs-Stage3 |
6.709600E-02 |
| Stage2-vs-Stage4 |
8.964400E-02 |
| Stage3-vs-Stage4 |
9.969800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.95319324550292E-14 |
| Normal-vs-AfricanAmerican |
7.767200E-04 |
| Normal-vs-Asian |
2.87790000053079E-07 |
| Caucasian-vs-AfricanAmerican |
2.623800E-01 |
| Caucasian-vs-Asian |
8.318800E-01 |
| AfricanAmerican-vs-Asian |
4.346800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.10702591327572E-15 |
| Normal-vs-Female |
6.60460575119259E-12 |
| Male-vs-Female |
4.935500E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.32560020924689E-10 |
| Normal-vs-Age(41-60Yrs) |
1.00508490419315E-12 |
| Normal-vs-Age(61-80Yrs) |
7.33929583773829E-11 |
| Normal-vs-Age(81-100Yrs) |
1.680970E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.581400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.490400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.260600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.592200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.536400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.313200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.378200E-01 |
| Classical-VS-Follicular |
2.246600E-01 |
| Classical-VS-Other |
1.959580E-01 |
| Classical-VS-Normal |
9.65361124372066E-12 |
| Tall-VS-Follicular |
9.823200E-01 |
| Tall-VS-Other |
3.450600E-01 |
| Tall-VS-Normal |
2.06089999954528E-07 |
| Follicular-VS-Other |
4.160800E-01 |
| Follicular-VS-Normal |
1.4009999826925E-09 |
| Other-VS-Normal |
8.230900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.644529122937E-12 |
| Normal-vs-N1 |
4.13809986277158E-10 |
| N0-vs-N1 |
2.345200E-01 |
|
|
